IBT
MRUS

International Biotechnology Trust’s Merus MRUS Stock Holding History

International Biotechnology Trust’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-75,060
Closed -$1.14M – 49
2018
Q3 		$1.14M Hold
75,060
– – 0.54% 41
2018
Q2 		$1.69M Hold
75,060
– – 0.65% 38
2018
Q1 		$1.39M Buy
+75,060
New +$1.36M 0.54% 42
2017
Q3 		– Sell
-60,946
Closed -$966K – 60
2017
Q2 		$966K Buy
+60,946
New +$1.16M 0.37% 50

Other funds holding MRUS

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

International Biotechnology Trust's MRUS Position: Q4 2018 in Review

International Biotechnology Trust sold out of Merus (MRUS) in Q4 2018, closing a stake of 75,060 shares — an estimated $1.14M sold.

International Biotechnology Trust first reported a position in MRUS in Q2 2017 and held it in 4 quarters. The position peaked at $1.69M in Q2 2018. 26 funds tracked by Wall St. Rank hold MRUS as of Q4 2018.

  • International Biotechnology Trust reported no remaining Merus position as of Q4 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 75,060 Merus shares in Q4 2018, an estimated $1.14M.
  • International Biotechnology Trust first reported a position in Merus in Q2 2017 and held it in 4 quarters.
  • International Biotechnology Trust's Merus position peaked at $1.69M in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Merus as of Q4 2018.

Based on International Biotechnology Trust's 13F filing for Q4 2018, filed 14 Feb 2019.